Bionano Genomics Inc. (NASDAQ: BNGO)
$0.63
+0.0053 ( +0.84% ) 493.0K
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.
Market Data
Open
$0.63
Previous close
$0.63
Volume
493.0K
Market cap
$50.49M
Day range
$0.61 - $0.64
52 week range
$0.52 - $6.60
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 18 | Apr 05, 2024 |
ars | Annual reports | 1 | Mar 06, 2024 |
4 | Insider transactions | 1 | Mar 05, 2024 |
10-k | Annual reports | 119 | Mar 05, 2024 |
8-k | 8K-related | 18 | Mar 05, 2024 |
4 | Insider transactions | 1 | Mar 05, 2024 |
4 | Insider transactions | 1 | Mar 05, 2024 |
4 | Insider transactions | 1 | Mar 05, 2024 |
8-k | 8K-related | 20 | Feb 28, 2024 |
8-k | 8K-related | 17 | Jan 08, 2024 |